Consolidated Balance Sheets - USD ($)	Dec. 31, 2020	Dec. 31, 2019
Current assets
Cash and cash equivalents	$ 39,553,671	$ 12,581,136
Restricted cash	110,000	110,000
Prepaid expenses	1,813,902	862,344
Research and development tax rebate receivable	634,940	739,656
Other current assets	657,662	26,130
Total current assets	42,770,175	14,319,266
Furniture and equipment, net	20,632	34,350
Intangible assets, net	13,375	68,542
Right-of-use asset	18,053	50,479
Other assets	17,218	17,218
Total Assets	42,839,453	14,489,855
Current liabilities
Accounts payable	1,588,613	293,171
Accrued expenses	93,367	77,888
Payroll liabilities	963,665	899,420
Common stock warrant liability	13,003,075
Lease liability	18,053	39,371
Other current liabilities	4,748	12,892
Total current liabilities	15,671,521	1,322,742
Long term liabilities
Lease liability long term		11,108
Total Liabilities	15,671,521	1,333,850
Commitments and contingencies (Note 13)
Stockholders' equity
Preferred stock - $0.001 par value; 10,000,000 shares authorized; 621 and 671 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively	1	1
Common stock - $0.18 par value; 175,000,000 shares authorized; 47,548,835 and 9,130,984 shares issued and outstanding as of December 31, 2020 and December 31, 2019, respectively	8,558,778	1,643,565
Additional paid-in capital	129,887,146	104,912,480
Accumulated deficit	(111,898,992)	(94,071,040)
Total Stockholders' Equity	27,167,932	13,156,005
Total Liabilities and Stockholders' Equity	42,839,453	14,489,855
Series B Preferred Stock [Member]
Stockholders' equity
Additional paid-in capital - Series B convertible preferred stock	$ 620,999	$ 670,999